Grifols Therapeutics
UEI: UFQ3A7GKJ5C7
• CAGE: 6SLC6
Overview
Parent Awardee
Name
Grifols Therapeutics
Headquarters
Research Triangle Park, NC
United States
United States
Most Recent Award
Sept. 27, 2024
Calculating
Federal contract recipient
GRIFOLS THERAPEUTICS LLC
(UEI UFQ3A7GKJ5C7, CAGE 6SLC6)
is headquartered in Research Triangle Park NC.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in December 2004 and
federally registered in
October 2012.
Federal Award Analysis
Grifols Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
GRIFOLS THERAPEUTICS LLC
UEI
UFQ3A7GKJ5C7
CAGE Code
6SLC6
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Dec. 9, 2004
Initial Registration
Oct. 8, 2012
Last Registration
April 16, 2025
Registration Activation
April 16, 2025
Registration Expiration
April 14, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Manufacturer of Goods
Limited Liability Company
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Grifols Therapeutics
GSA Schedules and Price Lists
- Grifols Therapeutics
- PoP: 3/14/13 - 4/30/22 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $25,670,364